Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Xtant Medical Holdings stock has a consensus rating of "Strong Buy" and an average price target of $1.23. The average 1-year stock price forecast is 156.25% higher than the current stock price, while the lowest is $1.00 (+108.33%) and the highest is $1.50 (+212.50%).

Price Target: $1.23 (+156.25%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$1.23	$1.20	$1.50
Change	+108.33%	+156.25%	+150.00%	+212.50%

Analyst Ratings

The average analyst rating for Xtant Medical Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Zimmerman BTIG	BTIG	Strong Buy Reiterates $1	Strong Buy	Reiterates	$1	+108.33%	May 13, 2026
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $1.5 → $1	Strong Buy	Maintains	$1.5 → $1	+108.33%	Mar 31, 2026
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $1.5	Strong Buy	Maintains	$2 → $1.5	+212.50%	Nov 11, 2025
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $3	Strong Buy	Maintains	$2 → $3	+525.00%	May 16, 2024
Ryan Zimmerman BTIG	BTIG	Strong Buy Initiates $2	Strong Buy	Initiates	$2	+316.67%	Dec 5, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

98.66M

Decreased by -26.33%

from 133.93M

Revenue Next Year

108.12M

Increased by 9.59%

from 98.66M

EPS This Year

-0.03

from 0.03

EPS Next Year

0.01

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	55.26M	57.97M	91.30M	117.27M	133.93M	98.66M	108.12M
Revenue Growth	3.61%	4.90%	57.50%	28.44%	14.21%	-26.33%	9.59%
EPS	-0.06	-0.09	0.01	-0.12	0.03	-0.03	0.01
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	47.06
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	102.6M	114.4M
Avg	98.7M	108.1M
Low	93.6M	101.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-23.4%	15.9%
Avg	-26.3%	9.6%
Low	-30.1%	3.3%

EPS Forecast

EPS	2026	2027	2028
High	-0.01	0.04
Avg	-0.03	0.01
Low	-0.05	-0.02

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.